Pfizer Inc Stock Current Ratio

PFE Stock  USD 27.78  0.19  0.69%   
Pfizer Inc fundamentals help investors to digest information that contributes to Pfizer's financial success or failures. It also enables traders to predict the movement of Pfizer Stock. The fundamental analysis module provides a way to measure Pfizer's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pfizer stock.
The current year's Current Ratio is expected to grow to 1.74.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Pfizer Current Ratio Analysis

Pfizer's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Pfizer Current Ratio

1.74

Current Ratio

 = 

Current Asset

Current Liabilities

More About Current Ratio | All Equity Analysis

Current Pfizer Current Ratio

    
  1.59 X  
Most of Pfizer's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pfizer Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pfizer Current Ratio Driver Correlations

Understanding the fundamental principles of building solid financial models for Pfizer is extremely important. It helps to project a fair market value of Pfizer Stock properly, considering its historical fundamentals such as Current Ratio. Since Pfizer's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pfizer's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pfizer's interrelated accounts and indicators.
0.70.770.820.770.540.6-0.120.980.640.350.870.840.870.30.910.40.40.880.79-0.610.320.440.480.060.54-0.280.080.21-0.140.45-0.36-0.4
0.70.520.610.790.340.72-0.440.640.36-0.120.490.580.890.120.540.020.730.710.45-0.63-0.240.850.60.340.71-0.640.27-0.02-0.30.6-0.27-0.52
0.770.520.370.550.720.20.080.680.860.210.550.920.620.590.810.30.480.480.78-0.430.260.290.27-0.070.34-0.150.09-0.04-0.170.280.010.2
0.820.610.370.790.110.83-0.440.880.150.510.810.580.8-0.190.680.340.310.960.68-0.70.230.460.620.420.68-0.470.060.55-0.130.62-0.7-0.59
0.770.790.550.790.130.79-0.710.760.280.280.540.630.920.010.780.310.470.80.73-0.950.150.680.640.210.93-0.680.240.32-0.540.46-0.41-0.47
0.540.340.720.110.13-0.220.460.460.730.050.410.720.350.420.520.210.30.250.460.010.390.040.27-0.23-0.08-0.01-0.05-0.14-0.04-0.040.160.16
0.60.720.20.830.79-0.22-0.640.62-0.030.120.560.310.76-0.210.410.010.50.830.38-0.69-0.230.770.470.580.75-0.560.250.25-0.130.76-0.64-0.69
-0.12-0.440.08-0.44-0.710.46-0.64-0.170.34-0.170.05-0.05-0.480.4-0.21-0.12-0.24-0.35-0.290.820.1-0.53-0.49-0.36-0.890.71-0.28-0.410.57-0.280.340.34
0.980.640.680.880.760.460.62-0.170.550.460.890.80.840.20.90.50.310.910.81-0.640.380.380.50.10.56-0.250.050.33-0.080.45-0.42-0.42
0.640.360.860.150.280.73-0.030.340.550.030.380.710.380.850.70.180.210.290.53-0.170.30.090.0-0.350.040.110.03-0.280.02-0.030.330.2
0.35-0.120.210.510.280.050.12-0.170.460.030.430.370.2-0.210.430.66-0.140.320.65-0.370.48-0.390.180.040.250.03-0.180.86-0.090.18-0.450.15
0.870.490.550.810.540.410.560.050.890.380.430.670.730.050.680.450.350.820.64-0.360.240.240.450.180.32-0.11-0.230.350.050.56-0.49-0.42
0.840.580.920.580.630.720.31-0.050.80.710.370.670.720.330.870.480.460.650.9-0.550.390.310.510.090.47-0.260.040.18-0.160.35-0.150.08
0.870.890.620.80.920.350.76-0.480.840.380.20.730.720.040.760.320.630.860.71-0.780.070.690.690.260.8-0.620.070.26-0.410.58-0.38-0.51
0.30.120.59-0.190.010.42-0.210.40.20.85-0.210.050.330.040.39-0.02-0.02-0.070.160.060.06-0.06-0.31-0.54-0.170.330.08-0.50.1-0.230.550.29
0.910.540.810.680.780.520.41-0.210.90.70.430.680.870.760.390.570.210.720.9-0.730.570.280.46-0.160.59-0.250.080.24-0.280.15-0.15-0.17
0.40.020.30.340.310.210.01-0.120.50.180.660.450.480.32-0.020.57-0.160.250.66-0.420.55-0.280.26-0.260.320.14-0.320.47-0.09-0.070.020.13
0.40.730.480.310.470.30.5-0.240.310.21-0.140.350.460.63-0.020.21-0.160.40.3-0.31-0.430.650.460.490.43-0.520.01-0.01-0.240.67-0.2-0.13
0.880.710.480.960.80.250.83-0.350.910.290.320.820.650.86-0.070.720.250.40.67-0.670.210.590.610.420.65-0.490.140.35-0.080.61-0.61-0.62
0.790.450.780.680.730.460.38-0.290.810.530.650.640.90.710.160.90.660.30.67-0.730.510.170.540.090.63-0.31-0.030.5-0.270.3-0.240.07
-0.61-0.63-0.43-0.7-0.950.01-0.690.82-0.64-0.17-0.37-0.36-0.55-0.780.06-0.73-0.42-0.31-0.67-0.73-0.25-0.54-0.62-0.17-0.970.65-0.24-0.420.56-0.30.320.33
0.32-0.240.260.230.150.39-0.230.10.380.30.480.240.390.070.060.570.55-0.430.210.51-0.25-0.370.21-0.440.060.08-0.150.31-0.17-0.520.050.08
0.440.850.290.460.680.040.77-0.530.380.09-0.390.240.310.69-0.060.28-0.280.650.590.17-0.54-0.370.430.490.66-0.660.49-0.24-0.230.58-0.34-0.58
0.480.60.270.620.640.270.47-0.490.50.00.180.450.510.69-0.310.460.260.460.610.54-0.620.210.430.360.67-0.73-0.160.46-0.510.3-0.32-0.37
0.060.34-0.070.420.21-0.230.58-0.360.1-0.350.040.180.090.26-0.54-0.16-0.260.490.420.09-0.17-0.440.490.360.33-0.470.140.260.210.77-0.58-0.19
0.540.710.340.680.93-0.080.75-0.890.560.040.250.320.470.8-0.170.590.320.430.650.63-0.970.060.660.670.33-0.750.240.39-0.560.42-0.36-0.38
-0.28-0.64-0.15-0.47-0.68-0.01-0.560.71-0.250.110.03-0.11-0.26-0.620.33-0.250.14-0.52-0.49-0.310.650.08-0.66-0.73-0.47-0.75-0.15-0.260.66-0.350.310.41
0.080.270.090.060.24-0.050.25-0.280.050.03-0.18-0.230.040.070.080.08-0.320.010.14-0.03-0.24-0.150.49-0.160.140.24-0.15-0.250.070.13-0.33-0.16
0.21-0.02-0.040.550.32-0.140.25-0.410.33-0.280.860.350.180.26-0.50.240.47-0.010.350.5-0.420.31-0.240.460.260.39-0.26-0.25-0.280.25-0.56-0.06
-0.14-0.3-0.17-0.13-0.54-0.04-0.130.57-0.080.02-0.090.05-0.16-0.410.1-0.28-0.09-0.24-0.08-0.270.56-0.17-0.23-0.510.21-0.560.660.07-0.280.110.010.14
0.450.60.280.620.46-0.040.76-0.280.45-0.030.180.560.350.58-0.230.15-0.070.670.610.3-0.3-0.520.580.30.770.42-0.350.130.250.11-0.67-0.31
-0.36-0.270.01-0.7-0.410.16-0.640.34-0.420.33-0.45-0.49-0.15-0.380.55-0.150.02-0.2-0.61-0.240.320.05-0.34-0.32-0.58-0.360.31-0.33-0.560.01-0.670.49
-0.4-0.520.2-0.59-0.470.16-0.690.34-0.420.20.15-0.420.08-0.510.29-0.170.13-0.13-0.620.070.330.08-0.58-0.37-0.19-0.380.41-0.16-0.060.14-0.310.49
Click cells to compare fundamentals

Pfizer Current Ratio Historical Pattern

Today, most investors in Pfizer Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pfizer's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current ratio growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Pfizer current ratio as a starting point in their analysis.
   Pfizer Current Ratio   
       Timeline  
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition

Pfizer Discontinued Operations

Discontinued Operations

5.13 Million

At present, Pfizer's Discontinued Operations is projected to decrease significantly based on the last few years of reporting.
In accordance with the recently published financial statements, Pfizer Inc has a Current Ratio of 1.59 times. This is 45.36% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current ratio for all United States stocks is 26.39% higher than that of the company.

Pfizer Current Ratio Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pfizer's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pfizer could also be used in its relative valuation, which is a method of valuing Pfizer by comparing valuation metrics of similar companies.
Pfizer is currently under evaluation in current ratio category among related companies.

Pfizer ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pfizer's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pfizer's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Pfizer Fundamentals

About Pfizer Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pfizer Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pfizer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pfizer Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Current Ratio 0.91  1.74 

Pfizer Investors Sentiment

The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Pfizer's public news can be used to forecast risks associated with an investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Pfizer's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Pfizer's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Pfizer's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Pfizer.

Pfizer Implied Volatility

    
  52.55  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pfizer Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Pfizer Piotroski F Score and Pfizer Altman Z Score analysis.
Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Dividend Share
1.64
Earnings Share
0.37
Revenue Per Share
10.366
Quarterly Revenue Growth
(0.41)
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.